$BNTX fail in HNSCC vs. Pembro mono. But yeah, $MRNA ~70% POS for adjuvant lung, kidney, and bladder cancer is certainly conservative. https://t.co/j2ehWL8MoP https://t.co/gI4gyXrCyp
View original →Mostly looking for memes and biotech. No advice whatsoever.
Cite asCryptoQuant has tracked 53 directional calls by @med__twi on X since Nov 2016: tracked, not yet ranked (below the accuracy-scoring baseline) (as of Nov 11, 2026).
$BNTX fail in HNSCC vs. Pembro mono. But yeah, $MRNA ~70% POS for adjuvant lung, kidney, and bladder cancer is certainly conservative. https://t.co/j2ehWL8MoP https://t.co/gI4gyXrCyp
View original →$PHVS overdone here. Not sure if this is degrossing or if there are other reasons but this is definitively a nice asset at this price.
View original →Effizient market hypothesis in biotech. $CLDX $XBI https://t.co/vKrWqHisoN
View original →Going long $EVC <$10 seems like a good deal mid/long-term.
View original →I hope I will not jinx it again but MedTech seems to catch a bid finally. $IHI $XHE $BSX $ISRG et al.
View original →